Antiinfectives for Systemic Use, 3. Antivirals

View previous versions

Antiinfectives for Systemic Use, 3. Antivirals

Axel Kleemann, 

• https://doi.org/10.1002/14356007.c13_c01.pub3

HIV and AIDS Therapeutics

Pierre R. Bonneau, Bruno Simoneau, 

• https://doi.org/10.1002/14356007.c13_c01.pub2

HIV and AIDS Therapeutics

Pierre L. Beaulieu, John Proudfoot, 

• https://doi.org/10.1002/14356007.c13_c01

Axel Kleemann, 

Axel Kleemann

Hanau, Germany

Search for more papers by this author

Axel Kleemann, 

Axel Kleemann

Hanau, Germany

Search for more papers by this author

First published: 28 January 2022

https://doi.org/10.1002/14356007.c13_c01.pub4

Abstract

The article contains sections titled:

1	Introduction
2	J05A Direct Acting Antivirals
2.1	J05AB Nucleosides and Nucleotides Excluding Reverse Transcriptase Inhibitors (RTIs)
2.2	J05AC Cyclic Amines
2.3	J05AD Phosphonic Acid Derivatives
2.4	J05AE Protease Inhibitors
2.5	J05AF Nucleoside and Nucleotide Reverse Transcriptase Inhibitors (NRTIs)
2.6	J05AG Nonnucleoside Reverse Transcriptase Inhibitors (NNRTIs)
2.7	J05AH Neuraminidase Inhibitors
2.8	J05AP Antivirals for Treatment of HCV Infections
2.9	J05AR Antivirals for Treatment of HIV Infections, Combinations
2.10	J05AX Other Antivirals
	List of Abbreviations
	References

References

• 1De Clercq, E. (2007) Three Decades of Antiviral Drugs, Nat. Rev. Drug Discov. 6, 941.
  10.1038/nrd2485

  CAS Web of Science® Google Scholar
• 2De Clercq, E. (2007) The Design of Drugs for HIV and HCV, Nat. Rev. Drug Discov. 6, 1001–1018.
  10.1038/nrd2424

  CAS PubMed Web of Science® Google Scholar
• 3Gable, J.E., et al. (2014) Current and Potential Treatments for Ubiquitous but Neglected Herpesvirus Infections, Chem. Rev. 114, 11382–11412.
  10.1021/cr500255e

  CAS PubMed Web of Science® Google Scholar
• 4Jordheim, L.P., et al. (2013) Advances in the Development of Nucleoside and Nucleotide Analogues for Cancer and Viral Diseases, Nat. Rev. Drug Discov. 12, 447–464.
  10.1038/nrd4010

  CAS PubMed Web of Science® Google Scholar
• 5Esposito, F., et al. (2012) HIV-1 Reverse Transcriptase Still Remains a New Drug Target: Structure, Function, Classical Inhibitors, and New Inhibitors with Innovative Mechanisms of Actions, Mol. Biol. Internat. 58640123. doi: 10.1155/2012/586401.
  10.1155/2012/586401

  Google Scholar
• 6Flexner, C. (2007) HIV Drug Development: The Next 25 Years, Nat. Rev. Drug Discov. 6, 959–966.
  10.1038/nrd2336

  CAS PubMed Web of Science® Google Scholar
• 7Fraser, C., et al. (2014) Virulence and pathogenesis of HIV-1 infection: An evolutionary perspective, Science 343, 1243727-1-7. doi: 10.1126/science.1243727.
  10.1126/science.1243727

  Web of Science® Google Scholar
• 8Mehellou, Y. and De Clercq, E. (2010) Twenty-Six Years of Anti-HIV Drug Discovery: Where Do We Stand and Where Do We Go? J. Med. Chem. 53, 521–538.
  10.1021/jm900492g

  CAS PubMed Web of Science® Google Scholar
• 9Oversteegen, L., et al. (2007) HIV Combination Products, Nat. Rev. Drug Discov. 6, 951–952.
  10.1038/nrd2448

  CAS Web of Science® Google Scholar
• 10Wong, A. (2014) The HIV Pipeline, Nat. Rev. Drug Discov. 13, 649–650.
  10.1038/nrd4364

  CAS PubMed Web of Science® Google Scholar
• 11Zhan, P., et al. (2016) Anti-HIV Drug Discovery and Development: Current Innovations and Future Trends, J. Med. Chem. 59, 2849–2878.
  10.1021/acs.jmedchem.5b00497

  CAS PubMed Web of Science® Google Scholar
• 12 WHO (2015) Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection; What's New, WHO.
  Google Scholar
• 13Meanwell, N.A. and Watkins, W.J. (2014) Introduction to Hepatitis C Virus (HCV) Therapies Special Thematic Issue, J. Med. Chem. 57, 1625–1626. And following articles on new HCV therapeutics, e.g., Simeprevir, Asunaprevir, Danoprevir, Dasabuvir, Daclatasvir, Ledoipasvir and Ombitasvir.
  10.1021/jm5000936

  CAS PubMed Web of Science® Google Scholar
• 14Cannalire, R., et al. (2016) A Journey Around The Medicinal Chemistry of Hepatitis C Virus Inhibitors Targeting NS4B: From Target to Preclinical Drug Candidates, J. Med. Chem. 59, 16–41.
  10.1021/acs.jmedchem.5b00825

  CAS PubMed Web of Science® Google Scholar
• 15Manns, M.P., et al. (2007) The Way Forward in HCV Treatment–Finding the Right Path, Nat. Rev. Drug Discov. 6, 991–1000.
  10.1038/nrd2411

  CAS PubMed Web of Science® Google Scholar
• 16Manns, M.P. and von Hahn, T. (2013) Novel Therapies for Hepatitis C – One Pill Fits All? Nat. Rev. Drug Discov. 12, 595–610.
  10.1038/nrd4050

  CAS PubMed Web of Science® Google Scholar
• 17Sofia, M.J., et al. (2012) Nucleoside, Nucleotide, and Non-Nucleoside Inhibitors of Hepatitis C Virus NS5B RNA-Dependent RNA-Polymerase, J. Med. Chem. 55, 2481–2531.
  10.1021/jm201384j

  CAS PubMed Web of Science® Google Scholar
• 18Schaeffer, H.J., et al. (1978) Nature 272, 583.
  10.1038/272583a0

  CAS PubMed Web of Science® Google Scholar
• 19 Wellcome, (1980) US 4 199 574, GB-prior. 1974.
  Google Scholar
• 20Chang, P.K. and Welch, A.D. (1963) J. Med. Chem. 6, 428.
  10.1021/jm00340a019

  CAS PubMed Web of Science® Google Scholar
• 21 Roussel-Uclaf, (1963) GB 1 024 156, FR-prior. 1962.
  Google Scholar
• 22Lee, W.W., et al. (1960) J. Am. Chem. Soc. 82, 2648.
  10.1021/ja01495a070

  CAS Web of Science® Google Scholar
• 23 Parke Davis, (1971) US 3 616 208, USA-prior. 1967.
  Google Scholar
• 24Schabel, F.M. Jr. (1968) Chemotherapy 13, 321.
  10.1159/000220567

  CAS PubMed Web of Science® Google Scholar
• 25Witkowski, J.T., et al. (1972) J. Med. Chem. 15, 1150.
  10.1021/jm00281a014

  CAS PubMed Web of Science® Google Scholar
• 26 ICN, (1976) US 3 976 545, USA-prior. 1971.
  Google Scholar
• 27 ICN, (1979) US 4 138 547, USA-prior. 1977.
  Google Scholar
• 28Martin, J.C., et al. (1983) J. Med. Chem. 26, 759.
  10.1021/jm00359a023

  CAS PubMed Web of Science® Google Scholar
• 29 Syntex, (1983) US 4 355 032, USA-prior. 1981.
  Google Scholar
• 30 Syntex, (1983) US 4 423 050, USA-prior. 1981.
  Google Scholar
• 31 Syntex, (1985) US 4 507 305, USA-prior. 1981.
  Google Scholar
• 32Harnden, M.R., et al. (1989) J. Med. Chem. 32, 1738.
  10.1021/jm00128a012

  PubMed Web of Science® Google Scholar
• 33 Beecham, (1993) US 5 246 937, GB-prior. 1985.
  Google Scholar
• 34 Co Pharma Corp, (1986) US 4 567 182, IT-prior. 1981.
  Google Scholar
• 35 Burroughs Wellcome (1990) US 4 957 924, USAprior. 1987.
  Google Scholar
• 36Snoeck, R., et al. (1988) Antimicrob, Agents Chemother. 32, 1839.
  10.1128/AAC.32.12.1839

  CAS PubMed Web of Science® Google Scholar
• 37 Ceskoslovenska Akad., (1992) US 5 142 051, CS-prior. 1986.
  Google Scholar
• 38Harnden, M.R., et al. (1987) J. Med. Chem. 30, 1636.
  10.1021/jm00392a020

  CAS PubMed Web of Science® Google Scholar
• 39 Beecham, (1991) US 5 075 445, GB-prior. 1983.
  Google Scholar
• 40 Roche, (1997) US 5 700 936; USA-prior. 1996.
  Google Scholar
• 41 Syntex, (2000) US 6 083 953; USA-prior. 1994.
  Google Scholar
• 42 Rega Inst.VZW, (1984) US 4 424 211, USA-prior. 1979.
  Google Scholar
• 43Eastman, R.T., et al. (2020) Remdesivir: A Review of Its Discovery and Development, ACS Central Sci. 6, 672–683.
  10.1021/acscentsci.0c00489

  CAS PubMed Web of Science® Google Scholar
• 44Siegel, D., et al. (2017) J. Med. Chem. 60, 1648–1661.
  10.1021/acs.jmedchem.6b01594

  CAS PubMed Web of Science® Google Scholar
• 45Gilead, (2017) US 9 724 360, USA-prior. 2014.
  Google Scholar
• 46Coen, D.M. and Schaffer, P.A. (2003) Antiherpes Virus Drugs: A Promising Spectrum Of New Drugs And Drug Targets, Nat. Rev. Drug Discov. 2, 278–288.
  10.1038/nrd1065

  CAS PubMed Web of Science® Google Scholar
• 47Elion, G.B. (1989) The Purine Path to Chemotherapy (Nobel Lecture), Angew. Chem. Int. Ed. 28, 870–878. (History of Aciclovir Discovery).
  10.1002/anie.198908701

  Web of Science® Google Scholar
• 48 Du Pont, (1967) US 3 352 912, USA-prior. 1963.
  Google Scholar
• 49 Du Pont, (1971) US 3 592 934, USA-prior. 1963.
  Google Scholar
• 50 Du Pont, (1985) US 4 551 552, USA-prior. 1984.
  Google Scholar
• 51 Merz& Co., (1971) DE 1 941 218, DE-prior. 1969.
  Google Scholar
• 52Rosenthal, K.S., et al. (1982) Antimicrob. Agents Chemother. 22, 1031.
  10.1128/AAC.22.6.1031

  CAS PubMed Web of Science® Google Scholar
• 53Stetter, H., et al. (1960) Chem. Ber. 93, 226.
  10.1002/cber.19600930133

  CAS Web of Science® Google Scholar
• 54 DuPont, (1967) US 3 310 469, USA-prior. 1961.
  Google Scholar
• 55Nylen, P. (1924) Ber. Dtsch. Chem. Ges. 57b, 1023.
  10.1002/cber.19240570625

  CAS Google Scholar
• 56 DuPont, (1977) US 4 018 854, USA-prior. 1973.
  Google Scholar
• 57 Astra, (1982) US 4 339 445, SE-prior. 1976.
  Google Scholar
• 58Ghosh, A.K., et al. (2016) Recent Progress in the Development of HIV-1 Protease Inhibitors for the Treatment of HIV/AIDS, J. Med. Chem. ASAP. 59, 5172–5208.
  10.1021/acs.jmedchem.5b01697

  CAS PubMed Web of Science® Google Scholar
• 59Ghosh, A.K., et al. (2012) Enhancing Protein Backbone Binding – A Fruitful Concept for Combating Drug-Resistant HIV, Angew. Chem. Int. Ed. 51, 1778–1802.
  10.1002/anie.201102762

  CAS PubMed Web of Science® Google Scholar
• 60Izawa, K. and Onishi, T. (2006) Industrial Syntheses of the Central Core Molecules of HIV Protease Inhibitors, Chem. Rev. 106, 2811–2827.
  10.1021/cr050997u

  CAS PubMed Web of Science® Google Scholar
• 61Leung, D., et al. (2000) Protease Inhibitors: Current Status and Future Prospects, J. Med. Chem. 43, 305–341.
  10.1021/jm990412m

  CAS PubMed Web of Science® Google Scholar
• 62Parkes, K.E.B., et al. (1994) J. Org. Chem. 59, 3656.
  10.1021/jo00092a026

  CAS Web of Science® Google Scholar
• 63 Roche, (1993) US 5 196 438; GB-prior. 1989.
  Google Scholar
• 64Dorsey, B.D., et al. (1994) J. Med. Chem. 37, 3443.
  10.1021/jm00047a001

  CAS PubMed Web of Science® Google Scholar
• 65 Merck & Co, (1995) US 5 413 999; USA-prior. 1991.
  Google Scholar
• 66Abbott, (1996) US 5 541 206, USA-prior. 1989.
  Google Scholar
• 67Abbott, (1996) US 5 567 823, USA-prior. 1995.
  Google Scholar
• 68Abbott, (1997) US 5 635 523, USA-prior. 1989.
  Google Scholar
• 69Abbott, (2005) US 6 894 171, USA-prior. 1998.
  Google Scholar
• 70Kaldar, S.W., et al. (1997) J. Med. Chem. 40, 3979.
  10.1021/jm9704098

  PubMed Web of Science® Google Scholar
• 71Agouron, (1996) US 5 484 926, USA-prior. 1993.
  Google Scholar
• 72Vertex, (1996) US 5 585 397, USA-prior. 1992.
  Google Scholar
• 73Stoner, E.J., et al. (1999) Org. Process Res. Dev. 3, 145. 4, 264 (2000).
  10.1021/op980214p

  CAS Web of Science® Google Scholar
• 74Abbott, (1999) US 5 914 332, USA-prior. 1995.
  Google Scholar
• 75Abbott, (2006) US 7 141 593, USA-prior. 1999.
  Google Scholar
• 76Vertex, (2002) US 6 436 989, USA-prior. 1997.
  Google Scholar
• 77Smith Kline Beecham, (2003) US 6 514 953, GB-prior. 1998.
  Google Scholar
• 78Bold, G., et al. (1998) J. Med. Chem. 41, 3387.
  10.1021/jm970873c

  CAS PubMed Web of Science® Google Scholar
• 79Novartis, (1998) US 5 849 911, CH-prior. 1996.
  Google Scholar
• 80Bristol-Myers Squibb, (2000) US 6 087 383, USA-prior. 1998.
  Google Scholar
• 81Turner, S.R., et al. (1998) J. Med. Chem. 41, 3467.
  10.1021/jm9802158

  CAS PubMed Web of Science® Google Scholar
• 82Fors, K.S., et al. (1998) J. Org. Chem. 63, 7348.
  10.1021/jo9809229

  CAS PubMed Web of Science® Google Scholar
• 83Pharmacia & Upjohn, (1998) US 5 852 195, USA-prior. 1994.
  Google Scholar
• 84Upjohn Appl., (1995) EP 758 327, USA-prior. 1994.
  Google Scholar
• 85Gosh, A.K., et al. (2004) J. Org. Chem. 69, 7822.
  10.1021/jo049156y

  CAS PubMed Web of Science® Google Scholar
• 86Gosh, A.K., et al. (2006) J. Med. Chem. 48, 5252.
  10.1021/jm060561m

  CAS Web of Science® Google Scholar
• 87Tibotec, (2009) EP 1 725 566, EP-prior. 2003.
  Google Scholar
• 88Vertex, (2010) US 7 820 671, USA-prior. 2000.
  Google Scholar
• 89Venkatraman, S., et al. (2006) J. Med. Chem. 49, 6074.
  10.1021/jm060325b

  CAS PubMed Web of Science® Google Scholar
• 90Schering-Plough, (2003) US 7 012 066, USA-prior. 2001.
  Google Scholar
• 91Schering-Plough, (2012) US RE 43298, USA-prior. 2000.
  Google Scholar
• 92Rosenquist, A., et al. (2014) J. Med. Chem. 57, 1673.
  10.1021/jm401507s

  CAS PubMed Web of Science® Google Scholar
• 93Tibotec/Medivir, (2011) US 8 012 939, EP-prior. 2005.
  Google Scholar
• 94Glinski, R.P., et al. (1973) J. Org. Chem. 38, 4299.
  10.1021/jo00964a020

  CAS PubMed Web of Science® Google Scholar
• 95Horwitz, J.P., et al. (1964) J. Org. Chem. 29, 2076.
  10.1021/jo01030a546

  CAS Web of Science® Google Scholar
• 96Imazawa, M., et al. (1978) J. Org. Chem. 43, 3044.
  10.1021/jo00409a024

  CAS Web of Science® Google Scholar
• 97Burroughs Wellcome, (1988) US 4 724 232, GB-prior. 1985.
  Google Scholar
• 98McLaren, C., et al. (1991) Antiviral Chem. Chemother. 2, 321.
  10.1177/095632029100200601

  CAS Google Scholar
• 99Ajinomoto, (1990) US 4 970 148, JP-prior. 1987.
  Google Scholar
• 100Bristol-Myers Squibb, (1991) US 5 011 774, USA-prior. 1987.
  Google Scholar
• 101 US Dept. of Health, (1989) US 4 861 759, USA-prior. 1985.
  Google Scholar
• 102Lin, T.-S., et al. (1987) J. Med. Chem. 30, 440.
  10.1021/jm00385a033

  CAS PubMed Web of Science® Google Scholar
• 103US DHSS, (1989) US 4 879 277, USA-prior. 1985.
  Google Scholar
• 104Horwitz, J.P., et al. (1966) J. Org. Chem. 31, 205.
  10.1021/jo01339a045

  CAS PubMed Web of Science® Google Scholar
• 105Bristol-Myers, (1992) US 5 130 421, USA-prior. 1988.
  Google Scholar
• 106Beach, J.W., et al. (1992) J. Org. Chem. 57, 2217.
  10.1021/jo00034a006

  CAS Web of Science® Google Scholar
• 107IAF, (1991) US 5 047 407, USA-prior. 1989.
  Google Scholar
• 108Crimmins, M.T., et al. (1996) J. Org. Chem. 61, 4192.
  10.1021/jo960708p

  CAS PubMed Web of Science® Google Scholar
• 109Burroughs Wellcome, (1991) US 5 034 394, GB prior. 1988.
  Google Scholar
• 110Glaxo SmithKline, (2002) US 6 417 191, GB-prior. 1995.
  Google Scholar
• 111Gilead, (1998) US 5 733 788, USA-prior. 1996.
  Google Scholar
• 112Gilead, (1999) US 5 922 695, USA-prior. 1996.
  Google Scholar
• 113Holy, A., et al. (1987) Collect, Czech. Chem. Commun. 52, 2801.
  10.1135/cccc19872801

  CAS Web of Science® Google Scholar
• 114Ceskoslov. akad. vet., (1989) US 4 808 716, CS-prior. 1985.
  Google Scholar
• 115Starrett, J.E., et al. (1994) J. Med. Chem. 37, 1857.
  10.1021/jm00038a015

  CAS PubMed Web of Science® Google Scholar
• 116Academy of Sci. of Czech Republic and Rega Stichting v.z.w., (1997) US 5 663 159, USA-prior. 1990.
  Google Scholar
• 117Jeong, L.S., et al. (1993) J. Med. Chem. 36, 181.
  10.1021/jm00054a001

  CAS PubMed Web of Science® Google Scholar
• 118Gaede, B.J., et al. (2005) Org. Proc. Res. & Dev. 9, 23.
  10.1021/op040210m

  CAS Web of Science® Google Scholar
• 119Emory Univ, (1993) US 5 210 085, USA-prior. 1990.
  Google Scholar
• 120BioChem Pharma, (1996) US 5 538 975, GB-prior. 1991.
  Google Scholar
• 121Emory Univ, (1998) US 5 814 639, USA-prior. 1990.
  Google Scholar
• 122Emory Univ, (1999) US 5 914 331, USA-prior. 1990.
  Google Scholar
• 123Bisacchi, G.S., et al. (1997) Bioorg, Med. Chem. Lett. 7, 127.
  10.1016/S0960-894X(96)00594-X

  CAS Web of Science® Google Scholar
• 124Opio, C.K., et al. (2005) Nat. Rev./Drug Discov. 4, 535.
  10.1038/nrd1780

  CAS PubMed Web of Science® Google Scholar
• 125BMS, (1993) US 5 206 244, USA-prior. 1990.
  Google Scholar
• 126Velasco, J., et al. (2013) J. Org. Chem. 78, 5482.
  10.1021/jo400607v

  CAS PubMed Web of Science® Google Scholar
• 127Holy, A. (1972) Collect. Czech. Chem. Commun. 37, 4072.
  10.1135/cccc19724072

  CAS Web of Science® Google Scholar
• 128Idenix, (2003) US 6 596 700, USA-prior. 2000.
  Google Scholar
• 129Idenix, (2004) US 6 787 526, USA-prior. 2000.
  Google Scholar
• 130Gilead, (2010) US 7 803 788, USA-prior. 2000.
  Google Scholar
• 131Gilead, (2016) US 9 296 769, USA-prior. 2014.
  Google Scholar
• 132Derstine, B.P., et al. (2020) Org. Process Res. Dev. 24, 1420–1427.
  10.1021/acs.oprd.0c00078

  CAS Web of Science® Google Scholar
• 133Hargrave, K.D., et al. (1991) J. Med. Chem. 34, 2231.
  10.1021/jm00111a045

  CAS PubMed Web of Science® Google Scholar
• 134Boehringer Ing, (1994) US 5 366 972, USA-prior. 1989.
  Google Scholar
• 135Romero, D.L., et al. (1993) J. Med. Chem. 36, 1505.
  10.1021/jm00062a027

  CAS PubMed Web of Science® Google Scholar
• 136Upjohn, (1996) US 5 563 142, USA-prior. 1989.
  Google Scholar
• 137Young, S.D., et al. (1995) Antimicrob. Agents Chemother. 39, 2602.
  10.1128/AAC.39.12.2602

  CAS PubMed Web of Science® Google Scholar
• 138Thompson, A.S., et al. (1995) Tetrahedron Lett. 36, 8937.
  10.1016/0040-4039(95)01955-H

  Web of Science® Google Scholar
• 139Choudhury, A., et al. (2003) Org. Process Res. Dev. 7, 324.
  10.1021/op025595s

  CAS Web of Science® Google Scholar
• 140Merck & Co, (1996) US 5 519 021, USA-prior. 1992.
  Google Scholar
• 141Merck & Co, (1997) US 5 698 741, USA-prior. 1995.
  Google Scholar
• 142De Corte, B.L. (2005) J. Med. Chem. 48, 1689.
  10.1021/jm040127p

  CAS PubMed Web of Science® Google Scholar
• 143Janssen, (2006) US 7 037 917, EP-prior. 1999
  Google Scholar
• 144Janssen, P.A.J., et al. (2005) J. Med. Chem. 48, 1901.
  10.1021/jm040840e

  CAS PubMed Web of Science® Google Scholar
• 145Guillemont, J., et al. (2005) J. Med. Chem. 48, 2072.
  10.1021/jm040838n

  CAS PubMed Web of Science® Google Scholar
• 146Janssen, (2006) US 7 125 879, EP-prior. 2001.
  Google Scholar
• 147MSD, (2013) US 8 486 975, USA-prior. 2010.
  Google Scholar
• 148Gauthier, D.R., et al. (2015) Org. Lett. 17, 1353–1356.
  10.1021/ol503625z

  CAS PubMed Web of Science® Google Scholar
• 149Campeau, L.-C., et al. (2016) Org. Process Res. Dev. 20, 1476–1481.
  10.1021/acs.oprd.6b00163

  CAS Web of Science® Google Scholar
• 150McMullen, J.P., et al. (2018) Org. Process Res. Dev. 22, 1208–1213.
  10.1021/acs.oprd.8b00192

  CAS Web of Science® Google Scholar
• 151Enserink, M. (2013) Dueling Reviews for Controversial Flu Drug, Science 340, 508–509.
  10.1126/science.340.6140.1508

  Web of Science® Google Scholar
• 152von Itzstein, M. (2007) The War Against Influenza: Discovery and Development of Sialidase Inhibitors, Nat. Rev. Drug Discovery 6, 967–974.
  10.1038/nrd2400

  CAS PubMed Web of Science® Google Scholar
• 153Biota, (1994) US 5 360 817, AUS-prior. 1990.
  Google Scholar
• 154Chandler, M., et al. (1995) J. Chem. Soc. Perkin Trans. 1, 1173.
  10.1039/p19950001173

  Web of Science® Google Scholar
• 155Gilead, (1998) US 5 763 483, USA-prior. 1995.
  Google Scholar
• 156Chand, P., et al. (2001) J. Med. Chem. 44, 4379–4392.
  10.1021/jm010277p

  CAS PubMed Web of Science® Google Scholar
• 157Biocryst, (2003) US 6 562 861, USA-prior. 1997.
  Google Scholar
• 158Biocryst, (2014) US 8 778 997, USA-prior. 2006.
  Google Scholar
• 159Belema, M., et al. (2014) J. Med. Chem. 57, 2013.
  10.1021/jm401836p

  CAS PubMed Web of Science® Google Scholar
• 160Belema, M., et al. (2014) J. Med. Chem. 57, 5057.
  10.1021/jm500335h

  CAS PubMed Web of Science® Google Scholar
• 161BMS, (2012) US 8 303 944, USA-prior. 2006.
  Google Scholar
• 162Wang, P., et al. (2009) J. Org. Chem. 74, 6819–6824.
  10.1021/jo901345j

  CAS PubMed Web of Science® Google Scholar
• 163Ross, B.S., et al. (2011) J. Org. Chem. 76, 8311–8319.
  10.1021/jo201492m

  CAS PubMed Web of Science® Google Scholar
• 164Sofia, M., et al. (2010) J. Med. Chem. 53, 7202–7218.
  10.1021/jm100863x

  CAS PubMed Web of Science® Google Scholar
• 165Pharmasset, (2010), US 7,964,580, US-prior. 2007.
  Google Scholar
• 166Abbott, (2012) US 8 188 104, USA-prior. 2007.
  Google Scholar
• 167AbbVie, (2013) US 8 501 238, USA-prior. 2007.
  Google Scholar
• 168Mangion, I.K., et al. (2014) Org. Lett. 16, 2310.
  10.1021/ol500971c

  CAS PubMed Web of Science® Google Scholar
• 169Hughes, D.L. (2016) Org. Process Res. Dev. 20, 1404–1415.
  10.1021/acs.oprd.6b00241

  CAS Google Scholar
• 170MSD, (2011) US 7 973 040, USA-prior. 2008.
  Google Scholar
• 171MSD, (2014) US 8 871 759, USA-prior. 2009.
  Google Scholar
• 172Harper, S., et al. (2012) ACS Med. Chem. Lett. 3, 332–336.
  10.1021/ml300017p

  CAS PubMed Web of Science® Google Scholar
• 173Kuethe, J., et al. (2013) Org. Lett. 15, 4174–4177.
  10.1021/ol401864t

  CAS PubMed Web of Science® Google Scholar
• 174Williams, M.J., et al. (2016) Org. Lett. 18, 1852–1955.
  10.1021/acs.orglett.6b00590

  PubMed Web of Science® Google Scholar
• 175Link, J.O., et al. (2014) J. Med. Chem. 57, 2033.
  10.1021/jm401499g

  CAS PubMed Web of Science® Google Scholar
• 176Gilead, (2012) US 8 088 368, USA-prior. 2009.
  Google Scholar
• 177Gilead, (2014) US 8 822 430, USA-prior. 2009.
  Google Scholar
• 178Gilead Pharmasset, (2014) WO 2014 120981, USA-prior. 2013.
  Google Scholar
• 179DeGoey, D.A., et al. (2014) J. Med. Chem. 57, 2047.
  10.1021/jm401398x

  CAS PubMed Web of Science® Google Scholar
• 180AbbVie, (2010) US 8 691 938, USA-prior. 2009.
  Google Scholar
• 181AbbVie, (2014) US 8 680 106, USA-prior. 2013.
  Google Scholar
• 182Abbott & Enanta, (2013) US 8 420 596, USA-prior. 2008.
  Google Scholar
• 183AbbVie, (2014) US 8 691 938, USA-prior. 2009.
  Google Scholar
• 184Gilead, (2013) US 8 575 135, USA-prior. 2011.
  Google Scholar
• 185Gilead, (2014) US 8 921 341, USA-prior. 2011.
  Google Scholar
• 186Gilead, (2017) US 9 655 944, USA-prior. 2012.
  Google Scholar
• 187Gilead, (2016), US 9 296 782, USA-prior. 2013.
  Google Scholar
• 188Enanta, (2015), US 9 220 748, USA-prior. 2011.
  Google Scholar
• 189Kallemeyn, J.M., et al. (2020) Development of a Large-Scale Route to Glecaprevir: Synthesis of the Macrocycle via Intramolecular Etherification, Org, Process Res. Dev. 24, 1373–1392.
  10.1021/acs.oprd.0c00244

  CAS Web of Science® Google Scholar
• 190Hill, D.R., et al. (2020) Development of a Large-Scale Route to Glecaprevir: Synthesis of the Side Chain and Final Assembly, Org, Process Res. Dev. 24, 1393–1404.
  10.1021/acs.oprd.0c00245

  CAS Web of Science® Google Scholar
• 191AbbVie, (2015) US 8 937 150, USA-prior. 2011.
  Google Scholar
• 192AbbVie, (2017) US 9 586 978, USA-prior. 2011.
  Google Scholar
• 193Di Santo, R. (2014) Inhibiting the HIV Integration Process: Past, Present, and the Future, J. Med. Chem. 57, 539–566.
  10.1021/jm400674a

  CAS PubMed Web of Science® Google Scholar
• 194Palani, A. and Tagat, J.R. (2006) Discovery and Development of Small-Molecule Chemokine Coreceptor CCR5 Antagonists, J. Med. Chem. 49, 2851–2857.
  10.1021/jm060009x

  CAS PubMed Web of Science® Google Scholar
• 195LaBonte, J., et al. (2003) Nat. Rev. Drug Discov. 2, 345.
  10.1038/nrd1091

  CAS PubMed Web of Science® Google Scholar
• 196Matthews, T., et al. (2004) Nat. Rev. Drug Discov. 3, 215.
  10.1038/nrd1331

  CAS PubMed Web of Science® Google Scholar
• 197Duke Univ, (1995) US 5 464 933, USA-prior. 1993.
  Google Scholar
• 198Trimeris, (2000) US 6 015 881, USA-prior. 1998.
  Google Scholar
• 199Duke Univ, (2000) US 6 133 418, USA-prior. 1995.
  Google Scholar
• 200Trimeris, (2002) US 6 475 491, USA-prior. 1995.
  Google Scholar
• 201Summa, V., et al. (2008) J. Med. Chem. 51, 5843.
  10.1021/jm800245z

  CAS PubMed Web of Science® Google Scholar
• 202Humphrey, G.R., et al. (2011) Org. Process Res. Dev. 15, 73.
  10.1021/op100257r

  CAS Web of Science® Google Scholar
• 203 IRBM, (2007) US 7 169 780, USA-prior. 2001.
  Google Scholar
• 204Merck & Co, (2010) US 7 754 731, USA-prior. 2004.
  Google Scholar
• 205Pfizer, (2003) US 6 667 314, GB-prior. 2000.
  Google Scholar
• 206Pfizer, (2009) US 7 576 097, GB-prior. 2000.
  Google Scholar
• 207Satoh, M., et al. (2006) J. Med. Chem. 49, 1506.
  10.1021/jm0600139

  CAS PubMed Web of Science® Google Scholar
• 208Japan Tobacco, (2007) US 7 176 220, JP-prior. 2002.
  Google Scholar
• 209Japan Tobacco, (2009) US 7 531 554, JP-prior. 2004.
  Google Scholar
• 210Johns, B.A., et al. (2013) J. Med. Chem. 56, 5901.
  10.1021/jm400645w

  CAS PubMed Web of Science® Google Scholar
• 211Shionogi & GSK, (2012) US 8 129 385, JP-prior. 2005.
  Google Scholar
• 212Shionogi & ViiV, (2014) US 8 778 943, JP-prior. 2005.
  Google Scholar
• 213Trofimov, F.A. et al., inventors, (1993) (US 5 198 552), PCT/SU-prior. 1989.
  Google Scholar
• 214 Shenyang Pharmaceut. University, (2011) US “7 960 427”, CN-prior. 2004.
  Google Scholar
• 215 Shenyang Pharmaceut. University, (2006) EP appl. 1 731 506 A1, CN-prior. 2004.
  Google Scholar
• 216Lischka, P., et al. (2010) Antimicrob. Agents Chemother. 54, 1290.
  10.1128/AAC.01596-09

  CAS PubMed Web of Science® Google Scholar
• 217Humphrey, G.R., et al. (2016) Org. Process Res. Dev. 20, 1097–1103.
  10.1021/acs.oprd.6b00076

  CAS Web of Science® Google Scholar
• 218Bayer, (2007) US 7 196 086, DE-prior. 2003.
  Google Scholar
• 219Aicuris, (2011) US 8 084 604, DE-prior. 2005.
  Google Scholar
• 220Aicuris, (2013) US 8 372 972, DE-prior. 2005.
  Google Scholar
• 221 Siga Technologies, (2010) US 7 737 168, USA-prior. 2003.
  Google Scholar
• 222 Siga Technologies, (2011) US 8 039 504, USA-prior. 2003.
  Google Scholar
• 223 Siga Technologies, (2013) US 8 530 509, USA-prior. 2003.
  Google Scholar
• 224 Siga Technologies, (2016) US 9 339 466, USA-prior. 2010.
  Google Scholar
• 225Hughes, D.L. (2019) Org. Process Res. Dev. 23, 1298–1307.
  10.1021/acs.oprd.9b00144

  CAS Web of Science® Google Scholar
• 226 Shionogi, (2015) US 8 927 710, JP-prior. 2009.
  Google Scholar
• 227 Shionogi, (2015) US 8 987 441, JP-prior. 2010
  Google Scholar
• 228 Shionogi, (2017) US 9 815 835, JP-prior. 2009.
  Google Scholar
• 229Shionogi, (2019) US 10 392 406, JP-prior. 2015.
  Google Scholar
• 230Shionogi, (2020) US 10 759 814, JP-prior. 2016.
  Google Scholar
• 231Toyama Chemical, (2004) US 6 787 544, JP-prior. 1998, 1999.
  Google Scholar
• 232Toyama Chemical, (2004) US 6 800 629, JP-prior. 2000.
  Google Scholar
• 233Toyama Chemical, (2013), US 8 513 261, JP-prior. 2009.
  Google Scholar
• 234Fujifilm/Toyama Chemical, (2015) US 9 181 203, Jp-prior. 2010, 2011.
  Google Scholar
• 235MYR GmbH, (2018) EP appl. 3 392 267, EP-prior. 2017.
  Google Scholar
• 236MYR GmbH, (2021) US 10 925 925, EP-prior. 2017.
  Google Scholar
• 237MYR GmbH, (2018) US 2018/0228804 A1, EP-prior. 2014.
  Google Scholar
• 238MYR GmbH, (2018) US 2018/0296634 A1, EP-prior. 2017.
  Google Scholar
• 239MYR GmbH, (2016) WO 2016/055534 A2, EP-prior. 2014.
  Google Scholar
• 240Meanwell, N.A., et al. (2018) J. Med. Chem. 61, 62–80.
  10.1021/acs.jmedchem.7b01337

  CAS PubMed Web of Science® Google Scholar
• 241Chen, K., et al. (2014) J. Org. Chem. 79, 8757–8767.
  10.1021/jo5016008

  CAS PubMed Web of Science® Google Scholar
• 242 BMS-Team (2017) Comprehensive Description of Synthesis of BMS-663068 in 9 Parts, Org. Process Res. Dev. 21, 1091–1185.
  Google Scholar
• 243BMS, (2010) US 7 745 625, USA-prior. 2004.
  Google Scholar
• 244BMS, (2012) US 8 168 615, USA-prior. 2004.
  Google Scholar
• 245BMS, (2013) US 8 461 333, USA-prior. 2010.
  Google Scholar

Ullmann's Encyclopedia of Industrial Chemistry

Browse other articles of this reference work:

• BROWSE BY TOPIC
• BROWSE A-Z

• References

• Related

• Information

Close Figure Viewer

Previous FigureNext Figure

Caption